The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Drug Eluting Implant-Global Market Insights and Sales Trends 2024

Drug Eluting Implant-Global Market Insights and Sales Trends 2024

Publishing Date : Dec, 2023

License Type :
 

Report Code : 1878806

No of Pages : 117

Ask Your Query
Synopsis
The global Drug Eluting Implant market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Drug Eluting Implant in various end use industries. The expanding demands from the Hospitals, Clinics, Ambulatory Surgical Centers and Others, are propelling Drug Eluting Implant market. Rapamycin Eluting Implant, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Paclitaxel Eluting Implant segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Drug Eluting Implant, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Drug Eluting Implant market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Drug Eluting Implant market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Drug Eluting Implant sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Drug Eluting Implant covered in this report include Boston Scientific, Medtronic, Abbott, Lepu Medical, B. Braun Melsungen, MicroPort Scientific, Cook Medical, Terumo and Biosensors International, etc.
The global Drug Eluting Implant market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Boston Scientific
Medtronic
Abbott
Lepu Medical
B. Braun Melsungen
MicroPort Scientific
Cook Medical
Terumo
Biosensors International
Balton
AlviMedica Medical Technologies
Biotronik
Shandong JW Medical
Sino Medical
Beijing AMSINO
Global Drug Eluting Implant market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Drug Eluting Implant market, Segment by Type:
Rapamycin Eluting Implant
Paclitaxel Eluting Implant
Everolimus Eluting Implant
Others
Global Drug Eluting Implant market, by Application
Hospitals
Clinics
Ambulatory Surgical Centers
Others
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Drug Eluting Implant manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Drug Eluting Implant in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Index
1 Drug Eluting Implant Market Overview
1.1 Drug Eluting Implant Product Overview
1.2 Drug Eluting Implant Market Segment by Type
1.2.1 Rapamycin Eluting Implant
1.2.2 Paclitaxel Eluting Implant
1.2.3 Everolimus Eluting Implant
1.2.4 Others
1.3 Global Drug Eluting Implant Market Size by Type
1.3.1 Global Drug Eluting Implant Market Size Overview by Type (2018-2029)
1.3.2 Global Drug Eluting Implant Historic Market Size Review by Type (2018-2023)
1.3.3 Global Drug Eluting Implant Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Drug Eluting Implant Sales Breakdown by Type (2018-2023)
1.4.2 Europe Drug Eluting Implant Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific Drug Eluting Implant Sales Breakdown by Type (2018-2023)
1.4.4 Latin America Drug Eluting Implant Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa Drug Eluting Implant Sales Breakdown by Type (2018-2023)
2 Global Drug Eluting Implant Market Competition by Company
2.1 Global Top Players by Drug Eluting Implant Sales (2018-2023)
2.2 Global Top Players by Drug Eluting Implant Revenue (2018-2023)
2.3 Global Top Players by Drug Eluting Implant Price (2018-2023)
2.4 Global Top Manufacturers Drug Eluting Implant Manufacturing Base Distribution, Sales Area, Product Type
2.5 Drug Eluting Implant Market Competitive Situation and Trends
2.5.1 Drug Eluting Implant Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by Drug Eluting Implant Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Drug Eluting Implant as of 2022)
2.7 Date of Key Manufacturers Enter into Drug Eluting Implant Market
2.8 Key Manufacturers Drug Eluting Implant Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Drug Eluting Implant Status and Outlook by Region
3.1 Global Drug Eluting Implant Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Drug Eluting Implant Historic Market Size by Region
3.2.1 Global Drug Eluting Implant Sales in Volume by Region (2018-2023)
3.2.2 Global Drug Eluting Implant Sales in Value by Region (2018-2023)
3.2.3 Global Drug Eluting Implant Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global Drug Eluting Implant Forecasted Market Size by Region
3.3.1 Global Drug Eluting Implant Sales in Volume by Region (2024-2029)
3.3.2 Global Drug Eluting Implant Sales in Value by Region (2024-2029)
3.3.3 Global Drug Eluting Implant Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Drug Eluting Implant by Application
4.1 Drug Eluting Implant Market Segment by Application
4.1.1 Hospitals
4.1.2 Clinics
4.1.3 Ambulatory Surgical Centers
4.1.4 Others
4.2 Global Drug Eluting Implant Market Size by Application
4.2.1 Global Drug Eluting Implant Market Size Overview by Application (2018-2029)
4.2.2 Global Drug Eluting Implant Historic Market Size Review by Application (2018-2023)
4.2.3 Global Drug Eluting Implant Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Drug Eluting Implant Sales Breakdown by Application (2018-2023)
4.3.2 Europe Drug Eluting Implant Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific Drug Eluting Implant Sales Breakdown by Application (2018-2023)
4.3.4 Latin America Drug Eluting Implant Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa Drug Eluting Implant Sales Breakdown by Application (2018-2023)
5 North America Drug Eluting Implant by Country
5.1 North America Drug Eluting Implant Historic Market Size by Country
5.1.1 North America Drug Eluting Implant Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Drug Eluting Implant Sales in Volume by Country (2018-2023)
5.1.3 North America Drug Eluting Implant Sales in Value by Country (2018-2023)
5.2 North America Drug Eluting Implant Forecasted Market Size by Country
5.2.1 North America Drug Eluting Implant Sales in Volume by Country (2024-2029)
5.2.2 North America Drug Eluting Implant Sales in Value by Country (2024-2029)
6 Europe Drug Eluting Implant by Country
6.1 Europe Drug Eluting Implant Historic Market Size by Country
6.1.1 Europe Drug Eluting Implant Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Drug Eluting Implant Sales in Volume by Country (2018-2023)
6.1.3 Europe Drug Eluting Implant Sales in Value by Country (2018-2023)
6.2 Europe Drug Eluting Implant Forecasted Market Size by Country
6.2.1 Europe Drug Eluting Implant Sales in Volume by Country (2024-2029)
6.2.2 Europe Drug Eluting Implant Sales in Value by Country (2024-2029)
7 Asia-Pacific Drug Eluting Implant by Region
7.1 Asia-Pacific Drug Eluting Implant Historic Market Size by Region
7.1.1 Asia-Pacific Drug Eluting Implant Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Drug Eluting Implant Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific Drug Eluting Implant Sales in Value by Region (2018-2023)
7.2 Asia-Pacific Drug Eluting Implant Forecasted Market Size by Region
7.2.1 Asia-Pacific Drug Eluting Implant Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Drug Eluting Implant Sales in Value by Region (2024-2029)
8 Latin America Drug Eluting Implant by Country
8.1 Latin America Drug Eluting Implant Historic Market Size by Country
8.1.1 Latin America Drug Eluting Implant Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Drug Eluting Implant Sales in Volume by Country (2018-2023)
8.1.3 Latin America Drug Eluting Implant Sales in Value by Country (2018-2023)
8.2 Latin America Drug Eluting Implant Forecasted Market Size by Country
8.2.1 Latin America Drug Eluting Implant Sales in Volume by Country (2024-2029)
8.2.2 Latin America Drug Eluting Implant Sales in Value by Country (2024-2029)
9 Middle East and Africa Drug Eluting Implant by Country
9.1 Middle East and Africa Drug Eluting Implant Historic Market Size by Country
9.1.1 Middle East and Africa Drug Eluting Implant Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Drug Eluting Implant Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa Drug Eluting Implant Sales in Value by Country (2018-2023)
9.2 Middle East and Africa Drug Eluting Implant Forecasted Market Size by Country
9.2.1 Middle East and Africa Drug Eluting Implant Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Drug Eluting Implant Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 Boston Scientific
10.1.1 Boston Scientific Company Information
10.1.2 Boston Scientific Introduction and Business Overview
10.1.3 Boston Scientific Drug Eluting Implant Sales, Revenue and Gross Margin (2018-2023)
10.1.4 Boston Scientific Drug Eluting Implant Products Offered
10.1.5 Boston Scientific Recent Development
10.2 Medtronic
10.2.1 Medtronic Company Information
10.2.2 Medtronic Introduction and Business Overview
10.2.3 Medtronic Drug Eluting Implant Sales, Revenue and Gross Margin (2018-2023)
10.2.4 Medtronic Drug Eluting Implant Products Offered
10.2.5 Medtronic Recent Development
10.3 Abbott
10.3.1 Abbott Company Information
10.3.2 Abbott Introduction and Business Overview
10.3.3 Abbott Drug Eluting Implant Sales, Revenue and Gross Margin (2018-2023)
10.3.4 Abbott Drug Eluting Implant Products Offered
10.3.5 Abbott Recent Development
10.4 Lepu Medical
10.4.1 Lepu Medical Company Information
10.4.2 Lepu Medical Introduction and Business Overview
10.4.3 Lepu Medical Drug Eluting Implant Sales, Revenue and Gross Margin (2018-2023)
10.4.4 Lepu Medical Drug Eluting Implant Products Offered
10.4.5 Lepu Medical Recent Development
10.5 B. Braun Melsungen
10.5.1 B. Braun Melsungen Company Information
10.5.2 B. Braun Melsungen Introduction and Business Overview
10.5.3 B. Braun Melsungen Drug Eluting Implant Sales, Revenue and Gross Margin (2018-2023)
10.5.4 B. Braun Melsungen Drug Eluting Implant Products Offered
10.5.5 B. Braun Melsungen Recent Development
10.6 MicroPort Scientific
10.6.1 MicroPort Scientific Company Information
10.6.2 MicroPort Scientific Introduction and Business Overview
10.6.3 MicroPort Scientific Drug Eluting Implant Sales, Revenue and Gross Margin (2018-2023)
10.6.4 MicroPort Scientific Drug Eluting Implant Products Offered
10.6.5 MicroPort Scientific Recent Development
10.7 Cook Medical
10.7.1 Cook Medical Company Information
10.7.2 Cook Medical Introduction and Business Overview
10.7.3 Cook Medical Drug Eluting Implant Sales, Revenue and Gross Margin (2018-2023)
10.7.4 Cook Medical Drug Eluting Implant Products Offered
10.7.5 Cook Medical Recent Development
10.8 Terumo
10.8.1 Terumo Company Information
10.8.2 Terumo Introduction and Business Overview
10.8.3 Terumo Drug Eluting Implant Sales, Revenue and Gross Margin (2018-2023)
10.8.4 Terumo Drug Eluting Implant Products Offered
10.8.5 Terumo Recent Development
10.9 Biosensors International
10.9.1 Biosensors International Company Information
10.9.2 Biosensors International Introduction and Business Overview
10.9.3 Biosensors International Drug Eluting Implant Sales, Revenue and Gross Margin (2018-2023)
10.9.4 Biosensors International Drug Eluting Implant Products Offered
10.9.5 Biosensors International Recent Development
10.10 Balton
10.10.1 Balton Company Information
10.10.2 Balton Introduction and Business Overview
10.10.3 Balton Drug Eluting Implant Sales, Revenue and Gross Margin (2018-2023)
10.10.4 Balton Drug Eluting Implant Products Offered
10.10.5 Balton Recent Development
10.11 AlviMedica Medical Technologies
10.11.1 AlviMedica Medical Technologies Company Information
10.11.2 AlviMedica Medical Technologies Introduction and Business Overview
10.11.3 AlviMedica Medical Technologies Drug Eluting Implant Sales, Revenue and Gross Margin (2018-2023)
10.11.4 AlviMedica Medical Technologies Drug Eluting Implant Products Offered
10.11.5 AlviMedica Medical Technologies Recent Development
10.12 Biotronik
10.12.1 Biotronik Company Information
10.12.2 Biotronik Introduction and Business Overview
10.12.3 Biotronik Drug Eluting Implant Sales, Revenue and Gross Margin (2018-2023)
10.12.4 Biotronik Drug Eluting Implant Products Offered
10.12.5 Biotronik Recent Development
10.13 Shandong JW Medical
10.13.1 Shandong JW Medical Company Information
10.13.2 Shandong JW Medical Introduction and Business Overview
10.13.3 Shandong JW Medical Drug Eluting Implant Sales, Revenue and Gross Margin (2018-2023)
10.13.4 Shandong JW Medical Drug Eluting Implant Products Offered
10.13.5 Shandong JW Medical Recent Development
10.14 Sino Medical
10.14.1 Sino Medical Company Information
10.14.2 Sino Medical Introduction and Business Overview
10.14.3 Sino Medical Drug Eluting Implant Sales, Revenue and Gross Margin (2018-2023)
10.14.4 Sino Medical Drug Eluting Implant Products Offered
10.14.5 Sino Medical Recent Development
10.15 Beijing AMSINO
10.15.1 Beijing AMSINO Company Information
10.15.2 Beijing AMSINO Introduction and Business Overview
10.15.3 Beijing AMSINO Drug Eluting Implant Sales, Revenue and Gross Margin (2018-2023)
10.15.4 Beijing AMSINO Drug Eluting Implant Products Offered
10.15.5 Beijing AMSINO Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Drug Eluting Implant Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Drug Eluting Implant Industrial Chain Analysis
11.4 Drug Eluting Implant Market Dynamics
11.4.1 Drug Eluting Implant Industry Trends
11.4.2 Drug Eluting Implant Market Drivers
11.4.3 Drug Eluting Implant Market Challenges
11.4.4 Drug Eluting Implant Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Drug Eluting Implant Distributors
12.3 Drug Eluting Implant Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

Published By : QY Research

Why ‘The Market Reports’

In Business: Pre Sales Support: Post Sales Support: Turn Around Time: Clients Served: Clients Assisted: Client Types: Payment: Partners with: Number of reports: Custom Research: Report Availability: Report Delivery Format: Security:

Payments Accepted From

Connect with us at

Complete Secure Website

SiteLock